サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676059

細胞凍結保存の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Cell Cryopreservation Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 134 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
細胞凍結保存の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 134 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞凍結保存の世界市場規模は、2024年の237億9,000万米ドルから2033年には1,505億1,000万米ドルに成長し、2026～2033年の予測期間中に22.75％の堅調な年間平均成長率（CAGR）を示すと予測されます。

細胞凍結保存市場は、細胞ベースの治療、再生医療、バイオバンキング技術の進歩に対する需要の増加を背景に、大きく成長する展望です。細胞を極低温で冷却・保存し、生物学的活動を停止させるプロセスである凍結保存は、幹細胞、免疫細胞、生殖細胞など様々な種類の細胞の生存能力と機能性を維持するために不可欠です。個別化医療や革新的な治療アプローチが世界的に注目される中、効果的な凍結保存技術の必要性はますます高まっています。この市場には、凍結保存機器、凍結保護剤、保存ソリューションなど、幅広い製品とサービスが含まれ、これらはすべて、長期間にわたる生物学的サンプルの完全性を確保するために設計されています。

技術的進歩が細胞凍結保存市場を大きく形成しており、凍結保存法や機器の革新がプロセスの効率性と信頼性を高めています。自動化された凍結保存システムと先進的モニタリング技術の開発により、温度制御の精度が向上し、細胞の生存率を損なう可能性のある氷晶形成のリスクが低減しています。さらに、人工知能とデータ分析を凍結保存プロトコールに統合することで、研究者や臨床医が保存条件を最適化し、解凍後の細胞の挙動を予測できるようになっています。市場が進化を続ける中、研究開発を優先して凍結保存ソリューションを強化する企業が、拡大する需要の中でより大きなシェアを獲得する可能性が高いです。

さらに、細胞凍結保存市場は、ヒト細胞や組織の使用をめぐる規制の枠組みや倫理的配慮の影響をますます受けるようになっています。バイオバンクや研究機関が厳格な規制の遵守に努める中、標準化され検証された凍結保存プロトコールへの需要は高まり続けると考えられます。この動向は、細胞の取り扱いや保存に携わる職員のためのトレーニングや認証プログラムへの投資を促進し、ベストプラクティスの遵守を確実なものにしています。さらに、ライフサイエンスセグメントでは持続可能性と環境への責任が重視されるようになり、企業はエコフレンドリー凍結保存ソリューションを模索するようになっています。細胞ベースの治療と再生医療への注目が高まるにつれ、信頼性が高く効率的な凍結保存方法の必要性が最も重要になり、このダイナミックな市場で成功するためには、産業のニーズに合致した製品を提供する企業の位置づけが重要になります。

当レポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供できるよう、綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています。

市場概要：市場概要：定義、分類、産業の現状を含む市場の詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 細胞凍結保存産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 細胞凍結保存の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • 凍結保護剤（ジメチルスルホキシド（DMSO）、エチレングリコール、グリセロール、その他の薬剤）
  • 機器（フリーザー、インキュベーター、液体窒素供給タンク、凍結保存消耗品）

第6章 世界の細胞凍結保存市場分析：細胞タイプ別

  • 細胞タイプ別概要
  • 実績データと予測データ
  • 細胞タイプ別分析
  • 幹細胞
  • 卵細胞と胚細胞
  • 精子細胞
  • 肝細胞
  • その他

第7章 世界の細胞凍結保存市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 創薬・医薬品開発
  • 再生医療
  • 臓器移植
  • 臨床研究
  • その他

第8章 世界の細胞凍結保存市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 病院とクリニック
  • バイオテクノロジーと製薬会社
  • 研究・学術機関
  • 開発業務受託機関（CRO）

第9章 世界の細胞凍結保存市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 細胞凍結保存企業の競合情勢

  • 細胞凍結保存市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • PromoCell GmbH
  • BioLife Solutions Inc.
  • Merck KGaA
  • HiMedia Laboratories
  • Creative Biolabs
  • Corning Incorporated
  • GE Healthcare
  • Danaher Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents) Market Sales by Geography (USD MN)
  • Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables) Market Sales by Geography (USD MN)
  • Analysis Market by Cell Type (USD MN)
  • Stem Cells Market Sales by Geography (USD MN)
  • Oocytes And Embryotic Cells Market Sales by Geography (USD MN)
  • Sperm Cells Market Sales by Geography (USD MN)
  • Hepatocytes Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Drug Discovery And Development Market Sales by Geography (USD MN)
  • Regenerative Medicine Market Sales by Geography (USD MN)
  • Organ Transplantation Market Sales by Geography (USD MN)
  • Clinical Research Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals And Clinics Market Sales by Geography (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Global Cell Cryopreservation Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cell Cryopreservation Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell Cryopreservation Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Cell Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents) Market Sales by Geography (USD MN)
  • Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables) Market Sales by Geography (USD MN)
  • Global Market Analysis by Cell Type (USD MN)
  • Stem Cells Market Sales by Geography (USD MN)
  • Oocytes And Embryotic Cells Market Sales by Geography (USD MN)
  • Sperm Cells Market Sales by Geography (USD MN)
  • Hepatocytes Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Drug Discovery And Development Market Sales by Geography (USD MN)
  • Regenerative Medicine Market Sales by Geography (USD MN)
  • Organ Transplantation Market Sales by Geography (USD MN)
  • Clinical Research Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals And Clinics Market Sales by Geography (USD MN)
  • Biotechnology And Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113534

Global Cell Cryopreservation Market size is anticipated to grow from USD 23.79 Billion in 2024 to USD 150.51 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 22.75% during the forecast period of 2026 to 2033.

The Cell Cryopreservation market is poised for significant growth, driven by the increasing demand for cell-based therapies, regenerative medicine, and advancements in biobanking technologies. Cryopreservation, the process of cooling and storing cells at very low temperatures to halt biological activity, is essential for preserving the viability and functionality of various cell types, including stem cells, immune cells, and reproductive cells. As the global focus on personalized medicine and innovative therapeutic approaches intensifies, the need for effective cryopreservation techniques is becoming increasingly critical. This market encompasses a wide range of products and services, including cryopreservation equipment, cryoprotectants, and storage solutions, all designed to ensure the integrity of biological samples over extended periods.

Technological advancements are significantly shaping the Cell Cryopreservation market, with innovations in cryopreservation methods and equipment enhancing the efficiency and reliability of the process. The development of automated cryopreservation systems and advanced monitoring technologies is improving the precision of temperature control and reducing the risk of ice crystal formation, which can compromise cell viability. Additionally, the integration of artificial intelligence and data analytics in cryopreservation protocols is enabling researchers and clinicians to optimize storage conditions and predict cell behavior post-thaw. As the market continues to evolve, companies that prioritize research and development to enhance their cryopreservation solutions will likely capture a larger share of the growing demand.

Moreover, the Cell Cryopreservation market is increasingly influenced by regulatory frameworks and ethical considerations surrounding the use of human cells and tissues. As biobanks and research institutions strive to comply with stringent regulations, the demand for standardized and validated cryopreservation protocols will continue to rise. This trend is driving investment in training and certification programs for personnel involved in cell handling and storage, ensuring that best practices are followed. Furthermore, the growing emphasis on sustainability and environmental responsibility in the life sciences sector is prompting companies to explore eco-friendly cryopreservation solutions. As the focus on cell-based therapies and regenerative medicine expands, the need for reliable and efficient cryopreservation methods will be paramount, positioning companies that align their offerings with industry needs for success in this dynamic market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Cryopreservation Media Agent (Ethylene Glycol, Dimethyl Sulfoxide, Glycerol, Others)
  • Equipment Type (Freezers, Liquid Nitrogen Supply Tanks, Others)

By Application

  • Stem Cells
  • Oocytes Cells
  • Sperm Cells
  • Others

By End User

  • Pharmaceutical And Biotechnology Company
  • Research Institute
  • Others
  • COMPANIES PROFILED
  • PromoCell GmbH
  • BioLife Solutions Inc.
  • HiMedia Laboratories
  • Merck Group KGaA
  • Lonza
  • Thermo Fisher Scientific Inc.
  • Eppendorf Corporate
  • Sartorius AG
  • Creative Biolabs
  • Danaher Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CELL CRYOPRESERVATION INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Cell Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1 Overview by Product Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product Type
  • 5.4 Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents) Historic and Forecast Sales by Regions
  • 5.5 Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables) Historic and Forecast Sales by Regions

6 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY CELL TYPE

  • 6.1 Overview by Cell Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Cell Type
  • 6.4 Stem Cells Historic and Forecast Sales by Regions
  • 6.5 Oocytes And Embryotic Cells Historic and Forecast Sales by Regions
  • 6.6 Sperm Cells Historic and Forecast Sales by Regions
  • 6.7 Hepatocytes Historic and Forecast Sales by Regions
  • 6.8 Other Historic and Forecast Sales by Regions

7 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Drug Discovery And Development Historic and Forecast Sales by Regions
  • 7.5 Regenerative Medicine Historic and Forecast Sales by Regions
  • 7.6 Organ Transplantation Historic and Forecast Sales by Regions
  • 7.7 Clinical Research Historic and Forecast Sales by Regions
  • 7.8 Other Historic and Forecast Sales by Regions

8 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use
  • 8.4 Hospitals And Clinics Historic and Forecast Sales by Regions
  • 8.5 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
  • 8.6 Research And Academic Institutes Historic and Forecast Sales by Regions
  • 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions

9 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CELL CRYOPRESERVATION COMPANIES

  • 10.1. Cell Cryopreservation Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CELL CRYOPRESERVATION INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Sartorius AG
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. PromoCell GmbH
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. BioLife Solutions Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Merck KGaA
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. HiMedia Laboratories
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Creative Biolabs
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Corning Incorporated
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. GE Healthcare
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Danaher Corporation
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies